HLB SCIENCE Inc. (XKON:343090)

Market Cap	36.53B
Revenue	n/a
Net Income	n/a
Shares Out	16.38M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	992
Average Volume	6,841
Open	2,280.00
Previous Close	2,200.00
Day's Range	2,190.00 - 2,280.00
52-Week Range	1,611.00 - 6,600.00
Beta	0.04
RSI	55.37
Earnings Date	n/a

About HLB SCIENCE

HLB SCIENCE Inc. develops biological drugs with MoA to infectious diseases. Its pipeline includes DD-S052P, a candidate that exterminates germs and eliminates endotoxins; DD-A279, a new treatment to cure Alzheimer's Diseases by controlling LPS and Gram-negative bacteria; and DD-A514, a diagnosis kit for Alzheimer's diseases. The company was formerly known as Dandi Bio Science Co.,Ltd. and changed its name to HLB SCIENCE Inc. in March 2023. The company was founded in 2016 and is based in Seoul, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 343090